Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors.

Nagaya N, Uematsu M, Kojima M, Date Y, Nakazato M, Okumura H, Hosoda H, Shimizu W, Yamagishi M, Oya H, Koh H, Yutani C, Kangawa K.

Circulation. 2001 Oct 23;104(17):2034-8.

2.
3.

Therapeutic potential of ghrelin in the treatment of heart failure.

Nagaya N, Kangawa K.

Drugs. 2006;66(4):439-48. Review.

PMID:
16597162
4.

Cachexia in chronic heart failure: prognostic implications and novel therapeutic approaches.

Akashi YJ, Springer J, Anker SD.

Curr Heart Fail Rep. 2005 Dec;2(4):198-203. Review.

PMID:
16332313
5.

Insights into the pathogenesis of chronic heart failure: immune activation and cachexia.

Anker SD, Rauchhaus M.

Curr Opin Cardiol. 1999 May;14(3):211-6. Review.

PMID:
10358792
6.

Ghrelin, a novel growth hormone-releasing peptide, in the treatment of chronic heart failure.

Nagaya N, Kangawa K.

Regul Pept. 2003 Jul 15;114(2-3):71-7. Review.

PMID:
12832093
7.

The syndrome of cardiac cachexia.

Anker SD, Sharma R.

Int J Cardiol. 2002 Sep;85(1):51-66. Review.

PMID:
12163209
8.

Ghrelin improves left ventricular dysfunction and cardiac cachexia in heart failure.

Nagaya N, Kangawa K.

Curr Opin Pharmacol. 2003 Apr;3(2):146-51. Review.

PMID:
12681236
9.

Hormonal consequences and prognosis of chronic heart failure.

Attanasio P, Anker SD, Doehner W, von Haehling S.

Curr Opin Endocrinol Diabetes Obes. 2011 Jun;18(3):224-30. doi: 10.1097/MED.0b013e3283469505. Review.

PMID:
21494135
10.

Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.

Kjaer A, Hesse B.

Clin Physiol. 2001 Nov;21(6):661-72. Review.

PMID:
11722473
11.

[Chronic heart failure and cachexia: role of endocrine system].

Dei Cas A, Muoio A, Zavaroni I.

Minerva Cardioangiol. 2011 Dec;59(6):601-12. Review. Italian.

PMID:
19946251
12.

Ghrelin, a novel peptide hormone in the regulation of energy balance and cardiovascular function.

Ledderose C, Kreth S, Beiras-Fernandez A.

Recent Pat Endocr Metab Immune Drug Discov. 2011 Jan;5(1):1-6. Review.

PMID:
22074572
13.

Translational research of ghrelin.

Ueno H, Shiiya T, Nakazato M.

Ann N Y Acad Sci. 2010 Jul;1200:120-7. doi: 10.1111/j.1749-6632.2010.05509.x. Review.

PMID:
20633140
14.

Tumor necrosis factor in congestive heart failure: a mechanism of disease for the new millennium?

Ceconi C, Curello S, Bachetti T, Corti A, Ferrari R.

Prog Cardiovasc Dis. 1998 Jul-Aug;41(1 Suppl 1):25-30. Review.

PMID:
9715820
15.

Therapeutic applications of ghrelin to cachexia utilizing its appetite-stimulating effect.

Akamizu T, Kangawa K.

Peptides. 2011 Nov;32(11):2295-300. doi: 10.1016/j.peptides.2011.05.018. Review.

PMID:
21635929
16.

Recent insights on chronic heart failure, cachexia and nutrition.

Miján-de-la-Torre A.

Curr Opin Clin Nutr Metab Care. 2009 May;12(3):251-7. doi: 10.1097/MCO.0b013e32832a2171. Review.

PMID:
19363338
17.

Metabolic and nutritional disorders in cardiac cachexia.

Mustafa I, Leverve X.

Nutrition. 2001 Sep;17(9):756-60. Review.

PMID:
11527673
18.

Nutrition in heart failure: an update.

Sandek A, Doehner W, Anker SD, von Haehling S.

Curr Opin Clin Nutr Metab Care. 2009 Jul;12(4):384-91. doi: 10.1097/MCO.0b013e32832cdb0f. Review.

PMID:
19474718
19.

Ghrelin and its therapeutic potential for cachectic patients.

Ashitani J, Matsumoto N, Nakazato M.

Peptides. 2009 Oct;30(10):1951-6. doi: 10.1016/j.peptides.2009.07.002. Review.

PMID:
19595727
20.

Possible synergism of physical exercise and ghrelin-agonists in patients with cachexia associated with chronic heart failure.

Invernizzi M, Carda S, Cisari C; Società Italiana per lo Studio della Sarcopenia e della Disabilità Muscolo-Scheletrica (SISDIM)..

Aging Clin Exp Res. 2014 Aug;26(4):341-51. doi: 10.1007/s40520-013-0186-7. Review.

PMID:
24347122
Items per page

Supplemental Content

Support Center